News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Mark A. Heise, PhD

Articles by Mark A. Heise, PhD

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study

ByWilliam H. Herman, MD, MPH,Riad G. Dirani, PhD,Ruslan Horblyuk, MBA,M. Colleen O'Neill, BSc,Barbara Kravitz, MS,Mark A. Heise, PhD,Alan Bakst, PharmD, MBA,Martin I. Freed, MD,the RESULT St

April 1st 2005

Latest Updated Articles

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study
Published: April 1st 2005 | Updated:

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

Top 5 Most-Read Vaccine Content in 2025

Evidence Suggests Bidirectional Risk Between Ovarian, Colorectal Cancers

Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss

Top 5 Most-Watched Video Interviews of 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.